Ethyl 2-(4-aminopiperazin-1-yl)acetate is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds. Its structure, featuring both an ester and an aminopiperazine moiety, makes it a valuable building block for developing drugs targeting neurological and cardiovascular disorders. It is often employed in the preparation of compounds with potential antipsychotic, antidepressant, or antihypertensive properties. Additionally, its reactivity allows for further modification, enabling the creation of derivatives with enhanced pharmacological activities. Researchers also explore its use in designing molecules for treating infectious diseases, leveraging its ability to interact with biological targets effectively.